Exemplis Discimus 2004, 148(2):131-133

Pellentesque purus nisl, sodales non, accumsan sit amet, aliquam id, dolor.

Rail Fyaara, Lisa Magnusb, Liana Narsona, Malando Dabrinia, Elgar Faroamerb, Lyman Airertha, Keenan Oorhiesa, Raddi Cal-Delmonta
a Faculty of Endodontics, Sern Faculty Hospital, Republic of Kamino
b Faculty of Speech Therapy, Duro University Hospital, Bogden Republic

Nunc dolor est, aliquet id, pulvinar sit amet, dignissim at, mauris. Proin arcu velit, tristique vitae, rhoncus sed, fermentum eget, risus. Donec orci velit, pellentesque vitae, mattis eget, porta in, nibh. Pellentesque leo diam, luctus rhoncus, condimentum ac, facilisis quis, tellus. Vestibulum venenatis turpis sit amet mauris.. Curabitur dui orci, suscipit nec, pulvinar id, auctor blandit, velit. Nulla eget ligula vel elit bibendum facilisis. Ut mauris lacus, mollis tempor, porttitor id, elementum ut, magna.

Keywords: Phasellus tristique, Integer et dolor, Duis ligula, Ut sem, Donec quis sapien

Received: January 1, 1970; Accepted: December 5, 2004; Published: December 1, 2004 


References

  1. Štípek S, Borovanský J, Čejková J, Homolka J, Klener P, Lukáš M, Špičák J, Tesař V, Zeman M, Zima T, Žák A. (2000) Antioxidants and free radicals in health and disease. (in Czech) Praha: Grada Publishing, 2000.
  2. Nguyen-Khoa T, Massy ZA, Witko-Sarsat V, Canteloup S, Kebede M, Lacour B, Drüeke T, Descamps-Latscha B. (1999) Oxidized Low-Density Lipoprotein Induced Macrophage Respiratory Burst via Its Protein Moiety: A Novel Pathway in Atherogebesis? Biochem Biophys Res Comm 263, 804-809. Go to original source... Go to PubMed...
  3. Descamps-Latscha B, Witko-Sarsat V. (2001) Importance of oxidatively modified proteins in chronic renal failure. Kidney Int 59, 108-113. Go to original source...
  4. Descamps-Latscha B, Drüeke T, Witko-Sarsat V. (2001) Dialysis-Induced Oxidative Stress: Biological Aspects, Clinical Consequences, and Therapy. Semin Dial 14, 193-199. Go to original source... Go to PubMed...
  5. Witko-Sarsat V, Gausson V, Descamps-Latscha B. (2003) Are advanced oxidation protein products potential uremic toxins? Kidney Int 63, 11-14. Go to original source...
  6. Witko-Sarsat V, Friedlander M, Nguyen-Khoa T, Capeillre-Blandin C, Nguyen AT, Canteloup S, Dayer J-M, Jungers P, Drüeke T, Descamps-Latscha B. (1998) Advanced Oxidation Protein Products as Novel Mediators of Inflammation and Monocyte Activation in Chronic Renal Failure. J Immunol 161, 2524-253. Go to PubMed...
  7. Witko-Sarsat V et al. (1996) AOPP as a novel marker of oxidative stress in uremia. Kidney Int 49, 1304-1313. Go to original source... Go to PubMed...
  8. Witko-Sarsat V, Gausson V, Nguyen A-T, Touam M, Drüeke T, Santangelo F, Descamps-Latscha B. (2003) AOPP-induced activation of human neutrophil and monocyte oxidation metabolism: A potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 64, 82-91. Go to original source... Go to PubMed...
  9. Kaneda H, Taguchi J, Ogasawara K, Aitawa T, Ohno M. (2002) Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162, 221-225. Go to original source... Go to PubMed...
  10. Sener G, Tosun O, Sehirli AO, Kacmaz A, Arbak S, Ersoy Y, Ayanoglu- Dulger G. (2003) Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion. Life Sci 72, 2707-2718 . Go to original source... Go to PubMed...
  11. Demir S, Inal-Erden M. (1998) Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury. Clin Chim Acta 275, 127- 35. Go to original source... Go to PubMed...
  12. Sehirli AO, Sener G, Satiroglu H, Ayanoglu-Dulger G. (2003) Protective effect of N-acetylcysteine on renal ischemia/reperfusion injury in the rat. J Nephrol 16, 75-80. Go to PubMed...
  13. Fukuzawa K, Emre S, Senyuz O, Acarli K, Schwartz ME, Miller CM. (1995) N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation 59, 6-9. Go to original source... Go to PubMed...